Layan Ali Alkhoshaiban

Layan Ali Alkhoshaiban

Auto-generated profile, based on publicly available information

Layan Ali Alkhoshaiban


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 February 2026 in Healthcare
Verified
Journal Article
Open access
PDF file
LALayan Ali Alkhoshaiban
Layan Ali Alkhoshaiban
LALayan Alolayan
Layan Alolayan
SAShahad Salah Aleid
Shahad Salah Aleid
RAReham Naif Almutiri
Reham Naif Almutiri
NANorah Musaad Aljulaydan
Norah Musaad Aljulaydan
SASAUD ALSAHALI
SAUD ALSAHALI
Background: Visual impairment (VI) describes decreased visual function that interferes with an individual’s ability to perform daily activities, such as reading, driving, and other executive tasks. Providing optimal pharmaceutical care for this population can be challenging for pharmacists, as individuals with VI face numerous obstacles in managing their medications. This study explores the challenges experienced by pharmacists and visually impaired patients and aims to compare their points of view to identify existing gaps and propose recommendations to optimize medication use among individuals with VI. Method: A cross-sectional study was conducted between September 2024 and January 2025 among pharmacists (n = 152) and visually impaired patients (n = 31) in the Qassim Region of Saudi Arabia. Pharmacists completed a self-administered questionnaire, while data from visually impaired patients were collected via structured face-to-face interviews. Data analysis was performed using IBM SPSS Version 21, with a significance level set at p < 0.05. Results: A total of 152 pharmacists and 31 visually impaired individuals participated in the study. Only 5.3% of pharmacists had received training related to VI care, and most counseling was directed to caregivers rather than patients (80.3%). pharmacists with additional training in VI were significantly more likely to employ unique or appropriate packaging methods (p < 0.001), and male pharmacists were more likely to rely on caregivers during OTC counseling (p = 0.014). Among the visually impaired participants, 77.5% reported difficulty reading medication packages and 67.7% faced challenges entering pharmacies. Braille literacy was significantly higher among males (p = 0.018) and those with higher education (p = 0.022). Overall, 90.3% expressed a need for improved accessibility tools and communication support in pharmacies. Conclusions: Pharmacists showed confidence in assisting visually impaired patients; however, most lacked formal training and relied heavily on caregivers for communication. Visually impaired individuals also reported difficulties accessing pharmacies, reading medication labels, and receiving complete information from pharmacists. Based on these findings, implementing specialized training programs, expanding Braille and tactile labeling, and integrating assistive technologies within pharmacies are recommended to improve safety and equitable medication use.